Company Name:Vericel Corporation
CEO: Dominick Colangelo

Sector: Healthcare
Industry:Biotechnology

Exchange: NASDAQ Capital Market

Country: USA

Description: Vericel Corp is a fully integrated, commercial-stage biopharmaceutical company. The company operates in one reportable segment: the research, manufacture, and distribution of patient-specific, used in the treatment of specific diseases.


Key numbers

Market Capitalization:833561750
Shares Outstanding: 44695000
Float: 44282062.895
Next Earning Date:2020-03-06
TTm EPS: -0.3162
TTm Dividend Rate:
200 days moving average:17.36
50 days moving average: 16
One day percent Change: -2.12



2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31,
2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,